The boom in specialty pharmaceuticals is reshaping the pharmacy industry's market structure as 10 companies account for 70 percent of specialty pharmacy revenues, according to Adam J. Fein, CEO of the Drug Channels Institute and author of the study on pharmacy economics and the pharmaceutical supply chain.